1. Home
  2. HCAT vs CDXS Comparison

HCAT vs CDXS Comparison

Compare HCAT & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Health Catalyst Inc

HCAT

Health Catalyst Inc

N/A

Current Price

$1.46

Market Cap

134.7M

Sector

Technology

ML Signal

N/A

Logo Codexis Inc.

CDXS

Codexis Inc.

N/A

Current Price

$1.08

Market Cap

154.4M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
HCAT
CDXS
Founded
2008
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Major Chemicals
Sector
Technology
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
134.7M
154.4M
IPO Year
2019
2008

Fundamental Metrics

Financial Performance
Metric
HCAT
CDXS
Price
$1.46
$1.08
Analyst Decision
Hold
Buy
Analyst Count
5
8
Target Price
$1.77
★ $6.14
AVG Volume (30 Days)
393.6K
★ 846.3K
Earning Date
11-05-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 43.82
EPS
N/A
★ N/A
Revenue
★ $311,136,000.00
$138,590,000.00
Revenue This Year
N/A
$4.97
Revenue Next Year
N/A
$18.69
P/E Ratio
N/A
★ N/A
Revenue Growth
1.48
★ 32.30
52 Week Low
$0.96
$0.96
52 Week High
$3.36
$2.98

Technical Indicators

Market Signals
Indicator
HCAT
CDXS
Relative Strength Index (RSI) 38.23 36.20
Support Level $1.04 $0.96
Resistance Level $1.84 $1.24
Average True Range (ATR) 0.11 0.08
MACD -0.03 -0.02
Stochastic Oscillator 13.10 23.53

Price Performance

Historical Comparison
HCAT
CDXS

About HCAT Health Catalyst Inc

Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platform, analytics applications and support services and generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.

About CDXS Codexis Inc.

Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.

Share on Social Networks: